Proteome and transcriptome analysis suggests oligodendrocyte dysfunction in schizophrenia.
about
Proteomics Research in SchizophreniaEffect of MK-801 and Clozapine on the Proteome of Cultured Human Oligodendrocytes.Loss of function studies in mice and genetic association link receptor protein tyrosine phosphatase α to schizophrenia.The DISC1 Ser704Cys substitution affects centrosomal localization of its binding partner PCM1 in glia in human brainReduced myelin basic protein and actin-related gene expression in visual cortex in schizophreniaResequencing and association analysis of PTPRA, a possible susceptibility gene for schizophrenia and autism spectrum disorders.Expression of mutant human DISC1 in mice supports abnormalities in differentiation of oligodendrocytes.MK-801 treatment affects glycolysis in oligodendrocytes more than in astrocytes and neuronal cells: insights for schizophrenia.Extracellular matrix abnormalities in schizophreniaPerineuronal nets and schizophrenia: the importance of neuronal coatings.Phosphoproteomic differences in major depressive disorder postmortem brains indicate effects on synaptic function.Impact on intracortical myelination trajectory of long acting injection versus oral risperidone in first-episode schizophrenia.The proteome of schizophrenia.Quantitative temporal proteomic analysis of human embryonic stem cell differentiation into oligodendrocyte progenitor cells.Modeling psychiatric disorders: from genomic findings to cellular phenotypesProteomic approaches to unravel the complexity of schizophrenia.Systems biology, bioinformatics, and biomarkers in neuropsychiatry.Oligodendroglia and neurotrophic factors in neurodegeneration.Proteome of brain glia: the molecular basis of diverse glial phenotypes.Ion mobility-enhanced data-independent acquisitions enable a deep proteomic landscape of oligodendrocytes.The human oligodendrocyte proteome.Protective effects of haloperidol and clozapine on energy-deprived OLN-93 oligodendrocytes.Proteomics of the corpus callosum unravel pivotal players in the dysfunction of cell signaling, structure, and myelination in schizophrenia brains.Gene expression profiling of the dorsolateral and medial orbitofrontal cortex in schizophrenia.Proteomics tackling schizophrenia as a pathway disorder.β-catenin promoter ChIP-chip reveals potential schizophrenia and bipolar disorder gene network.Proteomics as a tool for understanding schizophrenia.Perinatal Asphyxia in Rat Alters Expression of Novel Schizophrenia Risk Genes.Novel schizophrenia risk factor pathways regulate FEZ1 to advance oligodendroglia development.Gene expression analysis in blood of ultra-high risk subjects compared to first-episode of psychosis patients and controls.Proteomic biomarkers for psychiatric disorders: a progress update.Increased density of DISC1-immunoreactive oligodendroglial cells in fronto-parietal white matter of patients with paranoid schizophrenia.
P2860
Q26766821-356A20D3-1B1E-4AFF-8E22-CA6D79D33DBCQ30388470-998341DE-A704-4E09-AB51-879180E8B4B5Q30462812-14C4FEEA-76E5-4CCD-8706-4AC9744587C7Q33878306-C351B49A-BB36-43A1-A006-EA8456B07020Q34295745-1705BB10-A07D-468F-AA67-F127863D5A08Q34506299-D52EE4F6-5E63-4EC4-AA40-7D9A96A005B7Q35115817-069260E3-E61A-45F7-A804-48361559C40EQ35598966-4E5678FF-F561-424C-8E5C-30BA2451194DQ35603175-7F7D854C-3DD6-4795-B493-B3CA2BA9C95AQ35660845-FC80AC71-5E48-41F9-ACCD-078B803824D3Q36377477-677E8863-4938-4E8C-8300-5A7E7C6F5FAEQ36597061-68B4F515-449D-4C75-93EE-3DB10244F09AQ36848272-DA9E6BF5-15ED-4A1D-8332-3744D524889AQ37058194-B5A55D78-DD9A-43C5-8ADC-8115C15AADC0Q37199033-7AC8C8AA-0E98-4C44-9315-4B8D6C45E66FQ37980246-8A5531FE-701E-4650-BDB0-E134EF8BBD46Q38069972-B75FDFF2-5E06-48C1-9FDA-001DEB1013B1Q38096248-61E9237B-6151-445C-A1B6-3D8862349438Q38152439-9867EE30-CC8C-4C6E-935E-6FDED9AB0879Q38371298-636592F1-55CD-473A-91B9-1FCCFB956EC9Q38442322-916035A3-6E82-4D80-BFA3-B8EF09D100C2Q39590683-517CC119-ED82-41FC-A7B0-1C655DF8A624Q40671746-1927A973-269C-4E22-B0F9-99E23D545393Q41874352-96B972F6-2726-429F-865B-1C923662CFE6Q42352224-BD266259-F7A4-4EE5-B237-1C9CF588ECB0Q42976183-A89BE75B-6128-488F-96B4-F6A6255F21A6Q43235632-D10DDF9F-DE7C-4008-AF6B-807E31EC94A1Q45925954-1CB1F5FF-4613-43D8-A1DC-900ECD9D1468Q47283974-72CFE376-6BF9-4F3F-9DD2-ABA7B925C703Q48788276-C821CB46-5FAB-470F-A884-09944AEF1C3BQ50763945-EB5466B3-CDB8-4F5D-B19E-EE811686324AQ52150395-49FB796A-08DB-40FB-BFE2-FBC82371B821
P2860
Proteome and transcriptome analysis suggests oligodendrocyte dysfunction in schizophrenia.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 August 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Proteome and transcriptome ana ...... dysfunction in schizophrenia.
@en
Proteome and transcriptome ana ...... dysfunction in schizophrenia.
@nl
type
label
Proteome and transcriptome ana ...... dysfunction in schizophrenia.
@en
Proteome and transcriptome ana ...... dysfunction in schizophrenia.
@nl
prefLabel
Proteome and transcriptome ana ...... dysfunction in schizophrenia.
@en
Proteome and transcriptome ana ...... dysfunction in schizophrenia.
@nl
P921
P1476
Proteome and transcriptome ana ...... dysfunction in schizophrenia.
@en
P2093
Daniel Martins-de-Souza
P304
P356
10.1016/J.JPSYCHIRES.2009.07.007
P577
2009-08-21T00:00:00Z